These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1338431)

  • 1. Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans.
    Iwase S; Mano T; Saito M; Ishida G
    Funct Neurol; 1992; 7(6):459-70. PubMed ID: 1338431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of the new centrally acting muscle relaxant (R)-(+)-3-phenyl-5-[2-(1-pyrrolidinylmethyl)butyryl]isoxazole hydrochloride.
    Otsu T; Kawabata H; Horikomi K; Tanada H; Sakai K; Matsubara A; Mizuchi A
    Arzneimittelforschung; 1997 Jun; 47(6):706-9. PubMed ID: 9239447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies of 1-(2,3-dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1- propanone hydrochloride (AD-2239), a centrally acting muscle relaxant.
    Ito T; Hori M; Furukawa K; Karasawa T; Kadokawa T
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):105-22. PubMed ID: 3839647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone.
    Yang SI; Park HY; Lee SH; Lee SJ; Han OY; Lim SC; Jang CG; Lee WS; Shin YH; Kim JJ; Lee SY
    Pharmacology; 2004 Jul; 71(3):150-6. PubMed ID: 15161997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study.
    Cabitza P; Randelli P
    Eur Rev Med Pharmacol Sci; 2008; 12(4):229-35. PubMed ID: 18727454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with eperisone in the treatment of acute low back pain.
    Beltrame A; Grangiè S; Guerra L
    Minerva Med; 2008 Aug; 99(4):347-52. PubMed ID: 18663343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies of the new centrally acting muscle relaxant 4'-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride.
    Morikawa K; Oshita M; Yamazaki M; Ohara N; Mizutani F; Kato H; Ito Y; Kontani H; Koshiura R
    Arzneimittelforschung; 1987 Mar; 37(3):331-6. PubMed ID: 3593447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic tolperisone for post-exercise muscle soreness causes reduced isometric force--a double-blind randomized crossover control study.
    Bajaj P; Arendt-Nielsen L; Madeleine P; Svensson P
    Eur J Pain; 2003; 7(5):407-18. PubMed ID: 12935792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats.
    Matsunaga M; Uemura Y; Yonemoto Y; Kanai K; Etoh H; Tanaka S; Atsuta Y; Nishizawa Y; Yamanishi Y
    Jpn J Pharmacol; 1997 Mar; 73(3):215-20. PubMed ID: 9127816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open experience with a new myorelaxant agent for low back pain.
    Sartini S; Guerra L
    Adv Ther; 2008 Oct; 25(10):1010-8. PubMed ID: 18836866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of muscle relaxant E.M.P.P. on afferent discharges of muscle spindle in man--an microneurographic analysis (author's transl)].
    Mano T; Miyaoka T
    No To Shinkei; 1981 Mar; 33(3):237-41. PubMed ID: 6454427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial.
    Chandanwale AS; Chopra A; Goregaonkar A; Medhi B; Shah V; Gaikwad S; Langade DG; Maroli S; Mehta SC; Naikwadi A; Pawar DR
    J Postgrad Med; 2011; 57(4):278-85. PubMed ID: 22120855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the myotonolytic activity of tizanidine, eperisone and afloqualone in mouse and rabbit.
    Coward DM; White TG
    J Int Med Res; 1989; 17(4):358-62. PubMed ID: 2792555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of NK433, a new centrally acting muscle relaxant.
    Sakitama K; Ozawa Y; Aoto N; Nakamura K; Ishikawa M
    Eur J Pharmacol; 1995 Jan; 273(1-2):47-56. PubMed ID: 7737318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eperisone Hydrochloride, a Muscle Relaxant, Is a Potent P2X7 Receptor Antagonist.
    Okada M; Nose T
    Chem Pharm Bull (Tokyo); 2024; 72(3):345-348. PubMed ID: 38556262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of NK433, a new centrally acting muscle relaxant, on masticatory muscle reflexes in rats.
    Ozawa Y; Komai C; Sakitama K; Ishikawa M
    Eur J Pharmacol; 1996 Feb; 298(1):57-62. PubMed ID: 8867920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of muscle relaxant E-0646 on human stretch reflex and responses].
    Yamazaki Y; Mano T; Iwase S
    No To Shinkei; 1991 Apr; 43(4):369-75. PubMed ID: 1888576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sigma receptor modulation of the muscle relaxant action of eperisone.
    Hasegawa Y; Kaku S; Araki H; Otomo S
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):157-9. PubMed ID: 1353001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical application of eperisone hydrochloride to neurogenic bladder].
    Murayama K; Katsumi T; Tajika E; Nakamura T
    Hinyokika Kiyo; 1984 Mar; 30(3):403-8. PubMed ID: 6464913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraneural recording of muscle sympathetic activity during epidural anesthesia in humans.
    Lundin S; Wallin BG; Elam M
    Anesth Analg; 1989 Dec; 69(6):788-93. PubMed ID: 2556060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.